moderate-severe CKD | End Stage Kidney Failure | ||
---|---|---|---|
Women | THIN cohort | ||
R2 statistic (%) | 56.19 (55.67 to 56.70) | 54.02 (51.67 to 56.37) | |
D statistic | 2.32 (2.30 to 2.34) | 2.22 (2.11 to 2.32) | |
ROC statistic | 0.875 (0.872 to 0.877) | 0.818 (0.803 to 0.833) | |
QResearch cohort | |||
R2 statistic (%) | 56.45 (55.40 to 57.50) | 55.39 (0.52.59 to 58.18) | |
D statistic | 2.33 (2.28 to 2.40) | 2.28 (2.15 to 2.41) | |
ROC statistic | 0.877 (0.873 to 0.880) | 0.843 (0.825 to 0.860) | |
Men | THIN cohort | ||
R2 statistic (%) | 57.41 (54.56 to 60.27) | 52.86 (50.55 to 55.17) | |
D statistic | 2.38 (2.24 to 2.51) | 2.17 (2.07 to 2.27) | |
ROC statistic | 0.875 (0.873 to 0.878) | 0.839 (0.827 to 0.850) | |
QResearch cohort | |||
R2 statistic (%) | 58.29 (55.31 to 61.26) | 56.65 (53.94 to 59.35) | |
D statistic | 2.42 (2.28 to 2.56) | 2.34 (2.21 to 2.47) | |
ROC statistic | 0.878 (0.874 to 0.882) | 0.846 (0.829 to 0.862) |